Journal
DRUG DISCOVERY TODAY
Volume 27, Issue 8, Pages 2235-2243Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2022.05.009
Keywords
Artificial intelligence; Database; Data integration; Data mining; Deep learning; Knowledge discovery; Natural products
Categories
Funding
- National Research Foundation, Singapore
Ask authors/readers for more resources
Natural products are a valuable resource for drug development, but analyzing their complex data is a challenge. Artificial intelligence techniques can help overcome this limitation. However, further work is needed in knowledge and resource development, as well as modeling considerations, limitations, and challenges.
Natural products (NPs) constitute a large reserve of bioactive compounds useful for drug development. Recent advances in high-throughput technologies facilitate functional analysis of therapeutic effects and NP-based drug discovery. However, the large amount of generated data is complex and difficult to analyze effectively. This limitation is increasingly surmounted by artificial intelligence (AI) techniques but more needs to be done. Here, we present and discuss two crucial issues limiting NP-AI drug discovery: the first is on knowledge and resource development (data integration) to bridge the gap between NPs and functional or therapeutic effects. The second issue is on NP-AI modeling considerations, limitations and challenges.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available